TNTakahiro Nishino

Takahiro Nishino

*This is an algorithmically generated author record based on publicly available information.

Takahiro Nishino has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Applicability of artificial sweeteners as markers of wastewater contamination in Japanese surface waters

    by Shusuke Takemine, Saki Shibamori, Kenshi Sankoda, Takahiro Nishino, Mamoru Motegi, Iori Mishima


  • Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study

    by Toshihiro Matsui, Tomoya Yoshida, Takahiro Nishino, Shigeru Yoshizawa, Tetsuji Sawada, Shigeto Tohma

    Objectives: Our objective was to investigate trends in the treatment of patients with late-onset rheumatoid arthritis (LORA) using data from the National Database of Rheumatic Diseases in Japan (NinJa). Methods: Patients registered in the National Database of Rheumatic Diseases in Japan were classified according to the disease onset: at <65 years (young-onset rheumatoid arthritis); at 65–74 years (early LORA); and at ≥75 years (late LORA). Chronological changes in the treatment and disease activity were compared. Results: A total of 7178, 13,171, 15,295, and 15,943 patients were evaluated in 2010, 2013, 2016, and 2019, respectively. In all groups, the use of methotrexate gradually decreased, whereas that of biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) increased; the use of tumor necrosis factor inhibitors decreased, whereas that of non-tumor necrosis factor inhibitors increased. LORA was characterized by more single DMARD use and less methotrexate and biological/targeted synthetic DMARD use. Tumor necrosis factor inhibitors and interleukin-6 inhibitors were used less frequently, whereas abatacept was utilized more frequently in late versus early LORA. Conventional synthetic DMARD (excluding methotrexate) and glucocorticoid use was higher in late versus early LORA. Conclusions: This analysis revealed chronological changes in the treatment of LORA in Japan. Differences between early and late LORA suggest that patients are not a homogeneous population.


  • Open Access

    A Case of Decreased Swallowing Function Due to Cardiac Myxoma

    by Sumiyo Akazawa, Seiko Miura, Yasuhiro Nagayoshi, Junya Fukushima, Takahiro Nishino, Hiroji Nagata, Taigo Nagayama, Kazuaki Nishiki, Taishi Fujii, Daisuke Sakamoto, et al.

    症例は77歳,男性.2年前からめまい・嚥下機能低下があり,むせ,血痰も伴い内科で精査が行われ,原因不明の嚥下機能低下による誤嚥性肺炎の入院歴がある.今回動悸・息切れを伴い近医受診した.心臓超音波検査では,左房内腫瘍が心拍動に伴って僧帽弁に嵌頓していた.当院心臓血管外科で緊急左房粘液腫摘出術,Patch Closureが施行された.摘出術後,嚥下機能が回復したことから術後Ortner症候群と診断された.嚥下機能低下,めまいの原因精査として心臓超音波検査が重要と考えられた一例を経験したので報告する.

  • Open Access

    Ecological Risk Assessment of Pharmaceuticals and Personal Care Products in the Water Environment of 15 Cities in Japan

    by Takahiro Nishino, Mika Kato, Yoshitaka Miyazawa, Toshiki Tojo, Daichi Asakawa, Masanori Okata, Chisato Matsumura, Yuki Haga, Takuya Kakoi, Hitomi Hasegawa, et al.

    To assess the ecological risk of pharmaceuticals and personal care products (PPCPs) to the water environment of several cities in Japan, major local environmental research institutes, a private company, and an academic institution launched a joint research project in 2019. Under this initiative, local environmental research institutes surveyed the concentrations of 46 types of PPCPs at 59 points distributed across 15 cities in Japan. IDEA Consultants, Inc. calculated the unknown values of predicted no-effect concentration (PNEC) of six chemicals (telmisartan, candesartan, fexofenadine, diphenhydramine, diphenyl sulfone, and ketotifen) through bioassay experiments on aquatic organisms. Among the researched chemicals, the concentrations of clarithromycin, 14-hydroxyclarithromycin, erythromycin, diclofenac, carbamazepine, and telmisartan exceeded the PNEC in at least one sampling point. However, ozone treatment removed most of these chemicals, except for certain phosphate ester flame retardants. The mass balance of chemicals in the Tamagawa River flowing through Tokyo Prefecture was calculated by multiplying the concentration of each chemical with the flow rate at each sampling point in the river. The measured load of most chemicals at each sampling point of the Tamagawa River coincided to a certain extent with the cumulative load accumulated from the tributaries and sewage treatment plants to the uppermost point (Nagata Bridge). However, the measured load of diclofenac was significantly smaller than the estimated values at each sampling point, suggesting that diclofenac photodegrades while flowing down the river.